Navigation Links
WebLib develops application for Elsevier's SciVerse applications
Date:12/13/2010

Amsterdam, 13 December 2010 Elsevier (www.elsevier.com), a world-leading publisher of scientific, technical and medical information products and services, today announced that as a result of a partnership with WebLib, a new application, HealthMash, is now available on SciVerse Applications beta (www.applications.sciverse.com/).

WebLib developed the HealthMash application to provide insights to scientific researchers with relevant biomedical concepts related to their searches including disorders, tests and diagnoses, treatments and drugs. The application uses a variety of semantic technologies and natural language processing tools. HealthMash is powered by WebLib's proprietary Health Knowledge Base, which is automatically generated from trusted health content sites, special semantic sources such as the National Library of Medicine's Medical Subject Headings Thesaurus, and the Unified Medical Language System as well as information from the Web.

"WebLib's HealthMash application is powered by our consumer Health Knowledge Base and our goal is to create a much larger Science Knowledge Base to support semantic search applications on SciVerse and the emerging Semantic Web," said Dr. Tamas Doszkocs, President and Chief Scientist, WebLib LLC.

The addition of HealthMash to the SciVerse Applications beta marketplace, which currently includes 17 applications, illustrates the capabilities of the new platform to advance the scientific search and discovery process. All applications in the market place are designed to improve researcher workflow and enhance the content within SciVerse.

"Our collaboration with WebLib, as well as other commercial and academic partners, aims to enhance researchers' productivity," explained Rafael Sidi, vice president of product management for Elsevier's Application Marketplace and Developer Network. "We look forward to expanding our collaboration with academic and commercial developers as well as providing additional innovative applications that will improve researchers' search and discovery experience."


'/>"/>

Contact: Jen Saunders
jsaunders@psbpr.com
212-752-8338
Elsevier
Source:Eurekalert

Related biology news :

1. Iowa State researcher develops new treatment method for canine eye diseases
2. Hypertension develops early, silently, in African-American men
3. MIT develops new way to fuse cells
4. Fujitsu Develops HDD Security Technology Based on Opal SSC Standards
5. When acute hepatitis develops into chronic hepatitis
6. MIT student develops new innovations to selectively kill cancer cells
7. CSHL team develops mouse models of leukemia that predict response to chemotherapy
8. HudsonAlpha investigator develops rapid response swine flu test
9. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
10. Epigentek Develops a New Method of Measuring Global DNA Methylation
11. GSU professor develops new method to help keep fruit, vegetables and flowers fresh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... recipients of 13 prestigious awards honoring scientists who have made ... in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
Breaking Biology Technology: